Global Diabetic Care Market Size, Market Share & Forecast 2022

Market Research Report

A quick peek into the report

1   REPORT OVERVIEW
1.1   REPORT SCOPE
1.2   REPORT COVERAGE
1.3   RESEARCH METHODOLOGY
1.3.1     DATA TRIANGULATION
1.3.2     TOP-DOWN APPROACH
1.3.3     BOTTOM-UP APPROACH
1.3.4     ASSUMPTIONS & LIMITATIONS
1.3.5     KEY DATA POINT SOURCES
1.3.5.1   KEY DATA POINTS FROM SECONDARY SOURCES
1.3.5.2   KEY DATA POINTS FROM PRIMARY SOURCES
1.4   REPORT DESCRIPTION

2 EXECUTIVE SUMMARY
2.1 GLOBAL MARKET SCENARIO

3   MARKET OVERVIEW
3.1   INTRODUCTION
3.2   DIABETES PREVALENCE WORLDWIDE
3.3   RISK FACTORS & APPROACH FOR DIABETES MANAGEMENT
3.4   KEY TRENDS IN DIABETIC CARE MARKET
3.5   ADVANCE TECHNOOGIES ENTERING INTO DIABETIC CARE

4   MARKET DYNAMICS
4.1   INTRODUCTION
4.2   MARKET DRIVERS
4.3   MARKET CHALLENGES
4.4   MARKET OPPORTUNITIES

5   COMPETITIVE INSIGHTS
5.1   KEY MARKET DEVELOPMENTS & STRATEGIES
5.1.1    PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
5.1.2    MERGERS & ACQUISITIONS
5.1.3    PRODUCTDEVELOPMENTS AND LAUNCHES
5.1.4    BUSINESSEXPANSION/CONTRACTS
5.1.5    PATENTS,APPROVALS AND CERTIFICATIONS
5.1.6    OTHERS (EVENTS & RECOGNITIONS)
5.2   PORTER'S FIVE FORCES ANALYSIS
5.2.1    BARGAINING POWER OF BUYERS
5.2.2    BARGAINING   POWER  OF  SUPPLIER
5.2.3    THREAT FROM SUBSTITUTE
5.2.4    THREAT OF NEW ENTRANT
5.2.5    INTENSITY OF COMPETITIVE RIVALRY

6   INDUSTRY ANALYSIS
6.1   REGULATIONS, CONSORTIUMS, CERTIFICATION, & STANDARDS
6.1.1.     CONSORTIUM
6.1.2.     ALLIANCE/ASSOCIATIONS
6.1.3    REGULATORY BODIES
6.1.3.1    FOOD AND DRUG ADMINISTRATION (FDA)
6.1.3.2    MEDICAL DEVICE REGULATION ACT
6.1.3.3    MOBILE MEDICAL APPLICATIONS: THE FDA REGULATORY APPROACH
6.2.   VALUE CHAIN ANALYSIS

7   GLOBAL DIABETIC CARE MARKET BY DIABETES TYPES
7.1   INTRODUCTION
7.2   TYPE 1 DIABETES
7.3   TYPE 2 DIABETES
7.4   GESTATIONAL DIABETES
7.5   OTHER DIABETES

8   GLOBAL DIABETIC CARE MARKET BY ECOSYSTEM PLAYERS
8.1   INTRODUCTION
8.2   DIABETIC CARE ECOSYSTEM CLASSIFICATION
8.3   MARKET STATISTICS

9   GLOBAL DIABETIC CARE MARKET BY DRUG TYPES
9.1   INTRODUCTION
9.2   MARKET STATISTICS
9.3   GLOBAL DIABETIC CARE DRUG MARKET: CLASSIFICATION,  DRIVERS & CHALLENGES
9.4   GLOBAL DIABETIC CARE MARKET VALUE, BY DRUG TYPES
9.5   DRUG DEVELOPMENT PROCESS
9.6   DRUG TYPES
9.6.1    INSULIN
9.6.2   ORAL ANTI-DIABETIC DRUGS
9.6.3   NON-INSULININJECTABLE DRUGS
9.7   SOME DIABETIC DRUGS
9.8   RECENT DEVELOPMENTS

10   GLOBAL DIABETIC CARE MARKET BY DEVICE TYPES
10.1   INTRODUCTION
10.2   MARKET STATISTICS
10.3   GLUCOSE MONITORING DEVICES
10.3.1   SMBG MONITORING
10.3.2   CGM DEVICE
10.4   INSULIN-DELIVERY DEVICES
10.5   RECENT DEVELOPMENTS

11   GLOBAL DIABETIC CARE MARKET BY MOBILE APPLICATION DEVELOPERS
11.1   INTRODUCTION
11.2   SOFTWARE
11.3   BIG DATA
11.4   MARKET STATISTICS
11.5   BENEFITS OF MOBILE APPS
11.6   DIABETES APPS: TYPES & DRIVERS
11.7   SOME OF THE KEY PRODUCTS IN THE DIABETIC CARE
11.7.1     MOBILE APPS MARKET
11.8   RECENT DEVELOPMENTS & KEY PLAYERS

12   GLOBAL DIABETIC CARE MARKET, BY END-USE APPLICATION
12.1   INTRODDUCTION
12.2   MARKET STATISTICS
12.3   PATIENT MONITORING
12.3.1   MARKET STATISTICS
12.3.2    KEY INSIGHTS, EXAMPLES & PLAYERS
12.4   DIAGNOSIS
12.4.1    MARKET STATISTICS
12.4.2   DIAGNOSIS APPLICATION: SOME USE CASES & KEY PLAYERS
12.5   EDUCATION & AWARENESS
12.5.1   MARKET STATISTICS
12.6   HEALTHCARE MANAGEMENT
12.6.1   MARKET STATISTICS
12.7   PREVENTION & WELLNESS
12.7.1    MARKET STATISTICS
12.8   TREATMENT
12.8.1   MARKET STATISTICS
12.9   OTHERS
12.9.1   MARKET STATISTICS
12.1   RECENT KEY DEVELOPMENTS

13   GLOBAL DIABETIC CARE MARKET, BY GEOGRAPHY
13.1   INTRODDUCTION
13.2   MARKET STATISTICS
13.3   THE AMERICAS
13.3.1   THE AMERICAS: KEY INSIGHTS
13.3.2   STATISTICS OF THE KEY COUNTRIES/TERRITORIES
13.3.3   MARKET STATISTICS
13.3.4   THE U.S.: MAJOR MARKET SHARE HOLDER
13.3.5   RECENT DEVELOPMENTS
13.4   EUROPE
13.4.1   EUROPE: KEY INSIGHTS
13.4.2   STATISTICS OF THE KEY COUNTRIES/TERRITORIES
13.4.3   MARKET STATISTICS
13.4.4   RECENT DEVELOPMENTS
13.5   APAC
13.5.1   APAC: KEY INSIGHTS
13.5.2   STATISTICS OF THE KEY COUNTRIES/TERRITORIES
13.5.3   MARKET STATISTICS
13.6   REST OF THE WORLD (ROW)
13.6.1   AFRICA: KEY INSIGHTS
13.6.2   MIDDLE EAST: KEY INSIGHTS
13.6.3   STATISTICS OF THE KEY COUNTRIES/TERRITORIES
13.6.4   MARKET STATISTICS

14   GLOBAL DIABETIC CARE MARKET: KEY PLAYERS
14.1   INTRODUCTION
14.2   ELI LILLY AND COMPANY
14.2.1    OVERVIEW
14.2.2    FINANCIALS
14.2.3    KEY DEVELOPMENTS
14.2.4    SWOT ANALYSIS
14.3   BAYER HEALTHCARE AG
14.3.1    OVERVIEW
14.3.2    FINANCIALS
14.3.3    KEY DEVELOPMENTS
14.3.4    SWOT ANALYSIS
14.4   NOVO NORDISK
14.4.1    OVERVIEW
14.4.2    FINANCIALS
14.4.3    KEY DEVELOPMENTS
14.4.4    SWOT ANALYSIS
14.5   SANOFI PHARMA
14.5.1    OVERVIEW
14.5.2    FINANCIALS
14.5.3    KEY DEVELOPMENTS
14.5.4    SWOT ANALYSIS
14.6   MEDTRONIC INCORPORATION
14.6.1    OVERVIEW & FINANCIALS
14.6.2    KEY DEVELOPMENTS
14.6.3    SWOT ANALYSIS
14.7   JOHNSON & JOHNSON
14.7.1    OVERVIEW & FINANCIALS
14.7.2    KEY DEVELOPMENTS
14.7.3    SWOT ANALYSIS
14.8   PFIZER
14.8.1    OVERVIEW & FINANCIALS
14.8.2    KEY DEVELOPMENTS
14.8.3    SWOT ANALYSIS
14.9   ASTRAZENECA
14.9.1    OVERVIEW & FINANCIALS
14.9.3    SWOT ANALYSIS
14.1   MERCK & CO., INC
14.10.1    OVERVIEW & FINANCIALS
14.10.3    SWOT ANALYSIS
14.11   ROCHE DIAGNOSTICS
14.11.1    OVERVIEW & FINANCIALS
14.11.3    KEY DEVELOPMENTS
14.11.4    SWOT ANALYSIS
14.12     BRISTOL-MYERS SQUIBB COMPANY
14.12.1    OVERVIEW & FINANCIALS
14.12.2    SWOT ANALYSIS
14.13   BOEHRINGER INGELHEIM GROUP
14.13.1    OVERVIEW & FINANCIALS
14.13.2    SWOT ANALYSIS
14.14   ABBOTT LABORATORIES
14.14.1    OVERVIEW & FINANCIALS
14.14.2    SWOT ANALYSIS
14.15   TAKEDA PHARMACEUTICAL COMPANY LIMITED
14.15.1    OVERVIEW & FINANCIALS
14.15.2    SWOT ANALYSIS
14.16   GLAXOSMITHKLINE PLC (GSK)
14.16.1    OVERVIEW
14.16.2    FINANCIALS
14.17   NOVARTIS
14.17.1    OVERVIEW & FINANCIALS
14.18   AT&T, INC.
14.18.1    OVERVIEW & FINANCIALS
14.19   AGAMATRIX, INC.
14.19.1    OVERVIEW & DEVELOPMENTS

15 LIST OF ACCRONYMS

Key Questions Answered in this Report

The answers to the following key questions can be found in the report:

• What are the major market drivers, challenges and opportunities of the Diabetic Care market and their use cases?

• What are the key trends and developments in the Diabetic Care market for different Diabetic Care management?

• What are the key developmental strategies in different applications across all regions?

• What are different types of Diabetic Care solutions and the latest Diabetic Care technologies?

• How will the key market players leverage on key developments such as Mergers and Acquisitions, Partnerships, and Product Launches among others?

• Which geographical region will lead the global Diabetic Care market by the end of the forecast period?

• Who are the key players in the Diabetic Care market?

• What are the key government regulations for different Diabetic Care solutions?

• What are different types of devices, drugs and mobile applications in Diabetic Care market and what are the applications in which they are being used?

• What are the different end-use applications in which Diabetic Care products are being used?

• What is the different used case scenarios considered under different end-use applications?

• What are the Diabetic Care market trends and key developments in different geographical regions?

Report Description

The gradual advancement and innovation of new Diabetic Care technologies are developing a concrete platform for further growth of Diabetic Care market. With the emergence of advanced technologies such as mobile health, precision medicine, smart sensors, wearable technologies, and 3D-printing into the field of Diabetic Care, there has been a rise in the overall demand of the newly developed Diabetic Care products. Presently, the main focus of the government initiatives is mainly towards developing non-invasive solutions, controlling the level of increase in diabetic population, and integrating advanced technologies to fulfill the unmet needs of the diabetic population.

Governmental regulations and standards are playing a major role in sustaining the growth and development of the Diabetic Care market. The main aim of these regulations is to make Diabetic Care more adaptable and focused towards different types of diabetic diseases and also provide modern mobile technologies to the diabetic population. The patients benefit indirectly through these regulations as it helps them save time and cuts-down the overall cost as the patients receive the required treatment for the disease. The Diabetic Care market growth is propelled by due to factors such as: increasing demand for non-invasive treatments, technological innovation and advancement, development of artificial pancreas, and government support and regulations.

This study includes an overview and analysis of the Diabetic Care market, by type of diabetes, ecosystem (drug manufacturers, device manufacturers and mobile application developers), end-use applications, and geographical regions, allowing the research to develop a comprehensive outlook of the market. The Diabetic Care market report presents a detailed and investigative study of the entire Diabetic Care ecosystem and provides a comprehensive insight into various forms of developments, trends and key participants. The different type of diabetes are categorized into three major categories, viz. type 1, type 2, and gestational, among others, in the report. All of the above mentioned report coverage parameters are discussed across different regions like The Americas, Europe, Asia Pacific (APAC), and Rest of the World (ROW).

While highlighting the key driving and restraining forces for this dynamic market, the report also provides a comprehensive section of the prominent consortiums, compliances, and regulatory bodies, and their involvement in the Diabetic Care market.

The research study tries to answer various aspects of the Diabetic Care market with the help of central factors driving the market, threats that can possibly slow down the overall market growth, and the current growth opportunities that are going to shape the future trajectory of market expansion of Diabetic Care solutions. The study takes into account Porter’s Five Force Model for an in-depth study of the Diabetic Care market and an assessment of the factors governing the same. The analysis builds on a well-compiled value chain giving a detailed understanding of the ecosystem market penetration in the domain of Diabetic Care.

Towards the end of the report, the readers will have a clear understanding of the market dynamics, major drivers and the underlying threats and challenges that the global Diabetic Care industry is subjected to, including the estimation of the industry’s growth in terms of production and revenue. The report includes the profiles of major players in the Diabetic Care market, like, Eli Lily and Company, Novo Nordisk and Sanofi Pharma among others, allowing the readers to get an insight into the various industry trends.

Market Overview

With the advancement of drug delivery technologies and blood glucose diagnostic devices, the Diabetic Care market has emerged as a fast developing sector in healthcare. The overall market growth is gaining speed as large number of government initiatives and research & development programs have been launched in the recent years. The legal approval of the artificial pancreas or surprising advances in cell therapy such as islet cell transplant, stem cell transplant, others) are foreseen as an opportunity in Diabetic Care management. With the emergence of advanced technologies such as mobile health, precision medicine, smart sensors, wearable technologies, and 3D-printing paving its way into Diabetic Care, there has been a rising demand for the newly developed Diabetic Care products.

Type 2 diabetes is holding the maximum market share and is expected to grow at 9.16% CAGR from 2015 to 2022. The other type of diabetes includes Type 1 diabetes, and gestational diabetes. Observing current trends, gestational diabetes segment is expected to grow at a high CAGR of 11.13% from 2015 to 2022. The gestational diabetes cases are increasing since in this disease, during pregnancy, the insulin hormone secretion gets misbalanced.

With the increasing level of research and development measures, it has been estimated that the demand for diabetic drugs will escalate in the coming future as the amount of diabetic population is increasing worldwide. The global Diabetic Care market, on the basis of ecosystem, is segmented into: drug manufacturers, device manufacturers, and mobile application developers.

Drug manufacturers were holding a market share of 66% in 2014 of the entire Diabetic Care market. The other segments of ecosystem include Device manufacturers and Mobile application developers. Observing the current pattern of trends, Healthcare ITs/Big Data companies are collaborating and entering into partnerships with healthcare providers, academic institutions, pharmaceuticals, and biotechnology companies to support the growth of the Diabetic Care market.

The global Diabetic Care market on the basis of end-use applications is classified into: patient monitoring, diagnosis, treatment, healthcare management, education & awareness, and prevention & wellness, among others. At present, patient monitoring is dominating the market and is expected to reach $24.03 billion by 2022, mostly since this application helps them to monitor the patient’s health and activity by using medical or wearable devices that are connected with mobile Health apps.

In Americas, existing players are integrating with new start-ups through partnerships and collaborations to capture the North American segment. North American local players are also aiming to capture the South American Diabetic Care market. Throughout the Asia-Pacific region, regulatory bodies are implementing policies to keep a check on latest technologies. The Americas is the largest contributor in the overall revenue generation in Diabetic Care, followed by the European region, and is expected to grow at a CAGR of 8.13% from 2015 to 2022. The Middle Eastern region is expected to show the fastest growth globally, and is expected to grow at 14.79% CAGR from 2015 to 2022. The APAC region is focusing more on technological development and introduction of new advanced tools into Diabetic Care systems, in order to develop specific therapies and solutions.